167 related articles for article (PubMed ID: 7799667)
1. [Vasculitis associated with a myelodysplastic syndrome: a report of 5 cases].
Fernández-Miranda C; García-Marcilla A; Martín M; Gil R; Vanaclocha F; Torres N; del Palacio A
Med Clin (Barc); 1994 Oct; 103(14):539-42. PubMed ID: 7799667
[TBL] [Abstract][Full Text] [Related]
2. Rheumatic manifestations in myelodysplastic syndromes.
Castro M; Conn DL; Su WP; Garton JP
J Rheumatol; 1991 May; 18(5):721-7. PubMed ID: 1865418
[TBL] [Abstract][Full Text] [Related]
3. Clinical, hematological and histomorphological profile of myelodysplastic syndrome.
Nigam S; Rani S; Singh T; Gupta S; Rakheja D; Gaiha M
J Assoc Physicians India; 2001 Apr; 49():430-4. PubMed ID: 11762613
[TBL] [Abstract][Full Text] [Related]
4. Vasculitides associated with malignancies: analysis of sixty patients.
Fain O; Hamidou M; Cacoub P; Godeau B; Wechsler B; Pariès J; Stirnemann J; Morin AS; Gatfosse M; Hanslik T; Belmatoug N; Blétry O; Cevallos R; Delevaux I; Fisher E; Hayem G; Kaplan G; Le Hello C; Mouthon L; Larroche C; Lemaire V; Piette AM; Piette JC; Ponge T; Puechal X; Rossert J; Sarrot-Reynauld F; Sicard D; Ziza JM; Kahn MF; Guillevin L
Arthritis Rheum; 2007 Dec; 57(8):1473-80. PubMed ID: 18050165
[TBL] [Abstract][Full Text] [Related]
5. [Immunologic phenomena as the first sign of myelodysplastic syndrome].
van Rijn RS; Wittebol S; Graafland AD; Kramer MH
Ned Tijdschr Geneeskd; 2001 Aug; 145(32):1529-33. PubMed ID: 11525083
[TBL] [Abstract][Full Text] [Related]
6. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
[TBL] [Abstract][Full Text] [Related]
7. Large-vessel arteritis and myelodysplastic syndrome: report of two cases.
Steurer M; Fritsche G; Tzankov A; Gotwald T; Sturm W; Konwalinka G; Gruber J
Eur J Haematol; 2004 Aug; 73(2):128-33. PubMed ID: 15245512
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
9. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
Ogasawara T; Yasuyama M; Kawauchi K
Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin A in myelodysplastic syndrome: a preliminary report.
Dixit A; Chatterjee T; Mishra P; Choudhary DR; Mahapatra M; Saxena R; Choudhry VP
Ann Hematol; 2005 Sep; 84(9):565-8. PubMed ID: 15809884
[TBL] [Abstract][Full Text] [Related]
11. [Two cases of therapy-related myelodysplastic syndrome].
Takahashi A; Nagoshi H; Yamakawa T; Fukumura R; Matsuoka R; Nomura M; Takahashi S; Isobe H; Ide K; Saito N
Rinsho Ketsueki; 1996 Jan; 37(1):53-9. PubMed ID: 8683868
[TBL] [Abstract][Full Text] [Related]
12. Isolated PACNS-like presentation of a systemic vasculitis complicating a myelodysplastic syndrome.
Incalzi RA; Arena V; Capelli A; Gambassi G
J Intern Med; 2004 Jun; 255(6):674-9. PubMed ID: 15147531
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
[TBL] [Abstract][Full Text] [Related]
14. [Two cases of classical polyarteritis nodosa associated with a low titre of MPO-ANCA].
Bohgaki T; Mukai M; Notoya A; Kohno M
Ryumachi; 2000 Feb; 40(1):9-15. PubMed ID: 10783660
[TBL] [Abstract][Full Text] [Related]
15. [Study on prognostic factors in twenty-five patients with myelodysplastic syndrome].
Toyama T; Uno H; Yamashita K; Kubuki Y; Suzuki M; Maeda K; Matsuoka H; Tsubouchi H
Gan To Kagaku Ryoho; 1995 Feb; 22(2):227-32. PubMed ID: 7857097
[TBL] [Abstract][Full Text] [Related]
16. Treatment with low-dose cytosine arabinoside followed by administration of macrophage colony-stimulating factor prolongs the survival of patients with RAEB, RAEB-T, or leukemic phase myelodysplastic syndrome: a pilot study.
Fukuhara T; Miyake T; Maekawa I; Kurosawa M; Suzuki S; Noto S; Mori A; Chiba K; Toyoshima T; Hirano T; Morioka M; Tsutsumi Y; Okabe M; Kakinoki Y
Int J Hematol; 2000 Jun; 71(4):366-71. PubMed ID: 10905057
[TBL] [Abstract][Full Text] [Related]
17. Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies.
Yee KW; Zeng Z; Konopleva M; Verstovsek S; Ravandi F; Ferrajoli A; Thomas D; Wierda W; Apostolidou E; Albitar M; O'Brien S; Andreeff M; Giles FJ
Clin Cancer Res; 2006 Sep; 12(17):5165-73. PubMed ID: 16951235
[TBL] [Abstract][Full Text] [Related]
18. Unusual complex hyperdiploid karyotypes in myelodysplastic syndromes.
Stamatoullas A; Callat MP; Marreiros S; Tilly H; Bastard C
Cancer Genet Cytogenet; 2006 Oct; 170(2):129-32. PubMed ID: 17011983
[TBL] [Abstract][Full Text] [Related]
19. Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia.
Kuendgen A; Knipp S; Fox F; Strupp C; Hildebrandt B; Steidl C; Germing U; Haas R; Gattermann N
Ann Hematol; 2005 Dec; 84 Suppl 1():61-6. PubMed ID: 16270213
[TBL] [Abstract][Full Text] [Related]
20. Myelodysplastic syndromes in patients under 50 years old: a single institution experience.
Breccia M; Mengarelli A; Mancini M; Biondo F; Gentilini F; Latagliata R; Mandelli F; Alimena G
Leuk Res; 2005 Jul; 29(7):749-54. PubMed ID: 15927670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
